The FY2025 (Dec) proxy of NovoCure names 17 peer companies for pay. Pay versus performance data of NovoCure for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Exelixis | ||
| Incyte | ||
| Align Technology | ||
| Insulet | ||
| Alnylam Pharmaceuticals | ||
| Teladoc Health | ||
| TransMedics Group | ||
| Immunocore Holdings | ||
| Zai Lab | ||
| Inspire Medical Systems | ||
| CRISPR Therapeutics AG | ||
| 10x Genomics | ||
| BeOne Medicines | Not disclosed | Not disclosed |
| Blueprint Medicines | Not disclosed | Not disclosed |
| Exact Sciences Corporation | Not disclosed | Not disclosed |
| Guardant Health | Not disclosed | Not disclosed |
| iRhythm Technologies | Not disclosed | Not disclosed |
17 companies
Changes by year
FY2023 (Dec) proxy
- AddedCRISPR Therapeutics AGpay peer group
- AddedInspire Medical Systemspay peer group
- RemovedModernapay peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.